Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $8.34 Analyst target: $7.70 Upside: -7.67%
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.